C

C4 Therapeutics
D

CCCC

6.67000
USD
-0.04
(-0.60%)
Market Closed
Volume
27,802
EPS
0
Div Yield
0
P/E
-3
Market Cap
388,984,794
News

Title: C4 Therapeutics

Sector: Healthcare
Industry: Biotechnology
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.